Cardiovascular Risk Stratification in Covid-19 | NCT04555187 | Trialant
CompletedObservationalUpdated Nov 7, 2023
Cardiovascular Risk Stratification in Covid-19
Cardiovascular Risk Stratification in Covid-19
ClinicalTrials.gov ID
NCT04555187
Lead Sponsor
Oregon Health and Science UniversityOTHER
Overall Status
Completed
Study Type
Observational
Enrollment
1,355Actual
Last Update Posted
Nov 7, 2023Actual
Start Date
Jun 8, 2020Actual
Primary Completion Date
Dec 1, 2021Actual
Completion Date
Dec 1, 2021Actual
Official Title
Cardiovascular Risk Stratification in Covid-19
Brief Summary
This retrospective double-cohort study seeks to:
Describe the cardiovascular manifestations and electrophysiological (EP) substrate in COVID-19 infection and their association with clinical outcomes; and
Develop a method of cardiovascular risk stratification in COVID-19
Covid19
Cardiovascular Risk Factor
No interventions
There are no interventions for this study.
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
age >=18y
available data on Covid19 test in the electronic medical record (either positive or negative)